AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Sattva Neelapu

Sattva Neelapu

M D Anderson Cancer Center University of Texas - Houston / United States
Others
AD Scientific Index ID: 1406939
MD Anderson Cancer Center
person_outline Sattva Neelapu's MOST POPULAR ARTICLES
1-) Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma New England Journal of Medicine 377 (26), 2531-2544, 2017
2-) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells Biology of blood and marrow transplantation 25 (4), 625-638, 2019
3-) Chimeric antigen receptor T-cell therapy—assessment and management of toxicities Nature reviews Clinical oncology 15 (1), 47-62, 2018
4-) Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial The lancet oncology 20 (1), 31-42, 2019
5-) Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors New England Journal of Medicine 382 (6), 545-553, 2020